using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
Published 8 months ago • 85 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
3:27
using ai to predict patient response to car-t cell therapy: analysis of the juliet trial
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:14
components of the car-hematotox model which allow for prediction of icaht following car-t
-
1:02
the use of car-t cell products in a real-world setting
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
0:59
the clinical implementation of car t-cell therapy
-
1:38
genome editing tools in t cell-based immunotherapies
-
3:05
car-t viability testing
-
3:07
the role of bridging and timing in car-t
-
1:22
sharing car t-cell data: an ebmt perspective
-
1:39
exploring the applications of car-ts beyond hematology and oncology
-
1:28
using lentiviral vectors to generate car-t cells
-
2:11
exploring strategies to mitigate t-cell exhaustion: treatment-free intervals & small molecules
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:15
car-t therapy: where is it going?
-
4:12
opportunities to improve car-t outcomes
-
1:55
mesenchymal stromal cells in 2020
-
1:19
insights into rapid car-t manufacturing processes and challenges in this space